• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压中的交感神经系统。

The sympathetic nervous system in hypertension.

作者信息

Abboud F M

出版信息

Clin Exp Hypertens A. 1984;6(1-2):43-60. doi: 10.3109/10641968409062550.

DOI:10.3109/10641968409062550
PMID:6697560
Abstract

Sympathetic drive can contribute not only to the acute adjustment to circulatory stresses but also to sustained elevation in vascular resistance and arterial pressure. In hypertensive animals and humans excessive sympathetic activity coupled with a possible genetic factor may result in defects in electrogenic ion transport of vascular muscle or in excessive vascular hypertrophy. Increased sympathetic activity and release of the neurotransmitter may occur as a result of defects of the efferent, afferent or central components of the sympathetic system. Several studies in various animal models and in humans are described to support the notion that the mosaic concept in hypertension may be embodied in a dual theory that includes a vascular muscle defect coupled with excessive sympathetic drive both of which may be of genetic or acquired origin. Almost regardless of the cause of hypertension, interruption of sympathetic efferent activity lowers arterial pressure.

摘要

交感神经驱动不仅有助于对循环应激的急性调节,还会导致血管阻力和动脉血压的持续升高。在高血压动物和人类中,过度的交感神经活动加上可能的遗传因素,可能导致血管平滑肌电生性离子转运缺陷或血管过度肥大。交感神经系统的传出、传入或中枢成分的缺陷可能导致交感神经活动增加和神经递质释放。本文描述了在各种动物模型和人类中的多项研究,以支持以下观点:高血压的镶嵌概念可能体现在一种双重理论中,该理论包括血管平滑肌缺陷和过度的交感神经驱动,两者可能源于遗传或后天因素。几乎无论高血压的病因如何,中断交感神经传出活动都会降低动脉血压。

相似文献

1
The sympathetic nervous system in hypertension.高血压中的交感神经系统。
Clin Exp Hypertens A. 1984;6(1-2):43-60. doi: 10.3109/10641968409062550.
2
The sympathetic system in hypertension. State-of-the-art review.
Hypertension. 1982 May-Jun;4(3 Pt 2):208-25.
3
Renal nerves and hypertension: an update.肾神经与高血压:最新进展
Fed Proc. 1985 Oct;44(13):2846-50.
4
Adrenergic nervous system in hypertension.高血压中的肾上腺素能神经系统。
Contrib Nephrol. 1985;49:145-55. doi: 10.1159/000411909.
5
Sympathetic control of the circulation in hypertension: lessons from autonomic disorders.高血压中循环系统的交感神经控制:自主神经紊乱的启示。
Curr Opin Nephrol Hypertens. 2003 Mar;12(2):175-80. doi: 10.1097/00041552-200303000-00008.
6
Sympatho-renal axis in chronic disease.慢性疾病中的交感-肾素轴。
Clin Res Cardiol. 2011 Dec;100(12):1049-57. doi: 10.1007/s00392-011-0335-y. Epub 2011 Jun 19.
7
Pathophysiology I: the kidney and the sympathetic nervous system.病理生理学 I:肾脏和交感神经系统。
EuroIntervention. 2013 May;9 Suppl R:R42-7. doi: 10.4244/EIJV9SRA8.
8
Physiological aspects of autonomic nervous system function.自主神经系统功能的生理学方面。
Curr Opin Neurol Neurosurg. 1993 Aug;6(4):518-23.
9
Importance of the renal nerves in the pathogenesis of experimental hypertension.肾神经在实验性高血压发病机制中的重要性。
Hypertension. 1982 Sep-Oct;4(5 Pt 2):III108-14. doi: 10.1161/01.hyp.4.5_pt_2.iii108.
10
Renal nerves in hypertension.高血压中的肾神经
Miner Electrolyte Metab. 1989;15(1-2):74-82.

引用本文的文献

1
Analysis of the Relationship between Recent Small Subcortical Infarcts and Autonomic Nervous Dysfunction.近期小皮质下梗死与自主神经功能障碍的关系分析。
Curr Neurovasc Res. 2024;21(2):166-176. doi: 10.2174/0115672026303708240321035356.
2
Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?交感神经系统是否参与代谢综合征的病理生理过程?
Front Physiol. 2015 Aug 25;6:234. doi: 10.3389/fphys.2015.00234. eCollection 2015.
3
Noninvasive continuous blood pressure measurement from the finger: optimal measurement conditions and factors affecting reliability.
基于手指的无创连续血压测量:最佳测量条件及影响可靠性的因素
J Clin Monit. 1987 Jan;3(1):6-13. doi: 10.1007/BF00770876.
4
A low dietary sodium intake reduces neuronal noradrenaline release and the blood pressure in spontaneously hypertensive rats.
Naunyn Schmiedebergs Arch Pharmacol. 1986 Apr;332(4):364-9. doi: 10.1007/BF00500088.